Liver cancer is the fourth most prevalent and the second most lethal cancer in China.
Hepatitis B virus (HBV) infection represents a major risk factor for hepatocellular carcinoma …

Significant improvements in the management of hepatocellular carcinoma (HCC) during the
past three years have urged the timely update of clinical guidelines in China. In brief, aMAP …

The high mortality rate associated with hepatocellular carcinoma (HCC) is partly due to the
high proportion of patients who present with advanced stage disease at diagnosis, for whom …

Background The dismal prognosis of hepatocellular carcinoma (HCC) is closely associated
with characteristics of the tumour microenvironment (TME). Recent studies have confirmed …

Purpose Conversion therapy gives some patients with initially unresectable hepatocellular
carcinoma (HCC) access to surgery. The purpose of this study was to evaluate the safety …

Introduction: The actual rate of conversion surgery and its prognostic advantages remain
unclear. This study aimed to assess the outcomes of salvage surgery after conversion …

Background Unresectable hepatocellular carcinoma (u-HCC) still accounts for the majority
of newly diagnosed HCC which with poor prognosis. In the era of systemic therapy …

Hepatocellular carcinoma (HCC) has been the fifth most common malignancy worldwide
and is the second most common cause of tumor-related mortality globally. In China, a high …

Hepatocellular carcinoma (HCC) is a major health concern worldwide, with limited
therapeutic options and poor prognosis. In recent years, immunotherapies such as immune …

Background To assess the perioperative safety, oncological outcomes, and determinants
influencing the oncological outcomes of salvage liver resection for initially unresectable …